Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats Avontuur, J.A.M.; Bruining, H.A.; Ince, C. 
Introduction
Coronary autoregulation is the ability of the coronary vasculature to maintain blood flow relatively constant durw x ing changes in perfusion pressure 1,2 . Among the physiological mechanisms that are known to influence autoregu-Ž lation are metabolic factors i.e., oxygen tension andror . tissue metabolites and the so-called 'myogenic response', which mediates constriction in response to increased transw x mural pressure 3 . By increasing vascular tone in response to increasing perfusion pressure, the myogenic autoregulatory response may be an important mechanism in keeping capillary hydrostatic pressure relatively constant w x and preventing excess flow to the microcirculation 4,5 .
Ž . Nitric oxide NO is a major endothelium derived relax-Ž . ing factor EDRF , formed from the precursor amino acid, ) Ž .
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L-arginine, and stimulates the enzyme soluble guanylate-Ž . cyclase GC in the smooth muscle cell which converts w x GTP to cGMP resulting in vascular relaxation 6 . In the coronary vessels NO plays an important role in the regulation of vascular tone and myocardial blood flow both in w x vivo and in the isolated heart preparation 7,8 . The increased release of NO is suggested to be responsible for the vascular relaxation and hypotension seen in states of w x sepsis and endotoxemia 6 . Recently it was found that endothelium-derived NO can counteract coronary autoregulation by opposing myogenic tone and that inhibition of NO synthesis results in improved coronary autoregulation w x in the isolated guinea pig heart and rabbit heart 9,10 . Furthermore, NO plays a role in myocardial reactive hyw x peremia 11,12 -i.e., the increase in flow following a period of coronary arterial occlusion.
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Ž . PII S 0 0 0 8 -6 3 6 3 9 7 0 0 1 3 2 -6 ( )During sepsis and endotoxemia the coronary circulation is often characterized by inappropriately high coronary flow rates secondary to coronary vasodilatation with unw x coupling of flow from metabolic demand 13, 14 . This massive coronary dilatation may depend on accelerated w x cardiac production of NO 15, 16 . We recently showed that inhibition of this increased NO synthesis can result in focal w x myocardial ischemia 17 . Since the basal release of NO w x can attenuate coronary autoregulation 9,10 , it is feasible to hypothesize that increased synthesis of NO, as in sepsis and endotoxemia, can interfere with the physiological process of flow regulation leading to dysfunction of coronary autoregulation and altered reactive hyperemic response.
In this study, we investigated coronary myogenic autoregulatory function in response to step-wise changes in perfusion pressure and myocardial reactive hyperemia after a stop of coronary flow in isolated hearts of normal and endotoxin-treated rats. To investigate the role of NO, we v Ž . used the L-arginine analogue N -nitro-L-arginine NNLA w x Ž . 18 , to inhibit NO synthesis and methylene blue MB w x 19 , to inhibit soluble guanylate-cyclase. To see if the effect of direct vasoconstriction was different from the effect of inhibition of NO synthesis, we used vasopressin, a direct smooth muscle constrictor that acts independently w x of the L-argininerNOrcGMP pathway 20 .
Methods

Experimental set-up
This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. The protocol was approved by the animal ethics board of our university. Male Wistar Ž . rats 300-360 g received either a sublethal dose of 0.7 Ž mgrkg body wt Escherichia coli endotoxin LPS, . 0127:B8, Sigma Chemical Co. or saline by intraperitoneal injection 12 h before the initiation of the experiments. In vivo measurements of hemodynamic parameters and w x plasma metabolites have been previously presented 17 . Endotoxin-treated animals showed elevated rectal temperature, decreased mean arterial blood pressure, increased heart rate, and increased plasma levels of lactate. Serum Ž y y . nitrateq nitrite NO q NO , the stable end-products of 2 3 NO production, were elevated in endotoxin-treated animals as a sign of increased systemic release of NO. Rats were Ž . anesthetized with ether, heparinized 0.5 ml, 100 IU ; the hearts were removed, immediately cooled in ice-cold perfusion medium, and rapidly arranged for constant pressure perfusion at 378C according to Langendorff. The perfusion Ž . medium consisted of mmolrl NaCl 128, KCl 4.7, MgCl 2 1, NaH PO 0.4, NaHCO 20.3, CaCl 1.3, glucose 5.0, 2 4 3 2 pyruvate 2.0, and was oxygenated with 95%O r5%CO . 2 2 All hearts were continuously paced at 5 Hz. To minimize the metabolic component of coronary autoregulation, the left ventricle was drained by a cannula in the apex so that Ž no external work was performed. Flow rates expressed as . milliliters per minute per gram of ventricular wet weight Ž were measured by an electromagnetic flow probe Skalar-. Medical in the aortic perfusion line. For the determination of effluent oxygen pressure the right pulmonary artery was cannulated and a constant fraction of the coronary effluent Ž was led along a Clark-type electrode YSI Biological Oxygen Monitor, model 5300, Yellow Springs Instru-. ments . The coronary influent was similarly monitored for oxygen pressure via a side arm of the aortic cannula. Ž Oxygen consumption in micromoles per minute per gram . of ventricular wet weight was calculated from the product of influent-effluent oxygen concentration difference and coronary flow.
Autoregulatory function protocol
Autoregulatory function was investigated by studying adjustments in coronary flow in response to step-wise w x changes in perfusion pressure 21 . Following stabilization at 60 mmHg perfusion pressure, perfusion pressure was first lowered to 20 mmHg and subsequently increased by step-wise changes in perfusion pressure of 10 mmHg at 3-min intervals to a maximum of 100 mmHg. At the end of this series of pressure changes, perfusion pressure was set at the initial value of 60 mmHg. When the flow was stable, the perfusion medium was switched to one containing 100 mmolrl NNLA or 5 mmolrl MB. After a 30-min interval to reach a new steady state, the step-wise changes in perfusion pressure were repeated. Hearts were perfused for a total of 130 minutes. MB was used in a concentration Ž . of 5 mmolrl since higher concentrations ) 20 mmolrl caused a paradoxical increase in coronary flow in control w x hearts, probably by non-specific toxic effects 22 .
In 5 hearts of the control and endotoxin-treated group, a Ž . supramaximum dose of nitroprusside 10 mmolrl , a nitrovasodilator that acts as an exogenous NO donor, was tested to obtain maximum vasodilatation. To see if the effect of direct vasoconstriction was different from the effect of inhibiting the release of the endogenous vasodilator NO, we repeated the protocol of pressure steps switching to vasopressin, a direct smooth muscle constrictor that acts independently of the L-argininerNOrcGMP pathway w x 20 , in a concentration of 1 nmolrl that caused approximately the same reduction in flow as NNLA did in 4 hearts of the control and endotoxin-treated group. In 4 separate hearts of the control group the effect of increasing flow similar to endotoxin-treated hearts with nitroprusside Ž . 0.1 mmolrl was tested. NNLA, MB, vasopressin and nitroprusside were diluted in the perfusate in their final concentration.
Hyperemic flow response
Myocardial reactive hyperemia is the increase in coronary flow following a period of coronary artery occlusion w x 23,24 . Reactive hyperemic flow response was investi-( )gated after a stop of coronary flow for 90 s in hearts of Ž control and endotoxin-treated animals n s 8 in both . groups . To study the contribution of NO in reactive hyperemic response, the flow stop was repeated after the perfusion medium was switched to one containing 100 mmolrl NNLA or 5 mmolrl MB in 4 hearts each. In 4 separate hearts of the control group the effect of increasing flow similar to endotoxin-treated hearts on reactive hyper-Ž emic flow response was tested with nitroprusside 0.1 . mmolrl . In 4 separate hearts of the endotoxin-treated group the effect of reducing flow similar to NNLA with vasopressin was tested.
Definitions and calculations
Autoregulatory function was quantified by an index Ž . w x ArI first described by Norris et al. 21 which compares the observed change in vascular conductance for a given change in pressure in relation to the calculated change in conductance assuming that flow remained constant:
where F is flow at pressure P, F and P are initial flow i i and pressure, respectively, D F s F y F and D P s P y P.
If conductance is unchanged or increases when pressure is Ž . increased passive vascular bed , then ArI F 0 and there is no autoregulation. If conductance decreases when pressure increases, then ArI ) 0 with a maximum value for ArI of 1.0, where coronary flow remains constant irrespective of w x pressure changes indicating perfect autoregulation 1 . Quantitative analyses of features characterizing the myocardial reactive hyperemic flow response were performed according to the criteria described by Coffman and Gregg w x Ž . Ž . 23 where flow debt ml s control flow rate mlrs = Ž . Ž . occlusion time s ; flow repayment ml s total flow Ž . volume during reactive hyperemia ml -control flow rate Ž . Ž . mlrs = duration of reactive hyperemia s ; flow repayment ratio s flow repayment r flow debt.
Statistics
All values are expressed as mean " s.e.m. Student's t-test for group comparisons or paired t-test where appropriate were used to statistically compare values. Linear regression analysis was performed to determine the relation between myocardial oxygen consumption and coronary flow. P -0.05 was taken as statistically significant. NS is used to denote 'not significant'.
Chemicals
NNLA, MB, vasopressin and nitroprusside were obtained from Sigma. All the other chemicals were obtained from Merck. v control heart and endotoxin-treated LPS heart before and after inhibition of the L-argininerNOrcGMP pathway with 100 mmolrl N -nitro-L-arginine Ž . Ž . Ž . NNLA or 5 mmolrl methylene blue MB and direct vasoconstriction with 1 nmolrl vasopressin VP . Note that endotoxin-treated hearts showed increased pressure-induced flow changes as compared to control which could be prevented by treatment with NNLA or MB, whereas vasopressin was less effective. . separate heart . In all 3 groups there was a linear relation between Ž . coronary flow and oxygen consumption all P -0.001 . Regression lines were not significantly different between groups with regard to slope or intercept.
Results
Effect of endotoxemia on coronary flow, oxygen consumption and autoregulatory function at Õarying perfusion pressure
. tested using nitroprusside 0.1 mmolrl n s 4 . Normal hearts with 0.1 mmolrl nitroprusside had increased coro-Ž . nary flows Fig. 2b . Oxygen consumption increased paral-Ž lel to the increase in flow 4.8 " 0.1 mmolrmin per gram . wet weight at 60 mmHg with a linear relation between Ž oxygen consumption and coronary flow y s 0.127x q 2 . Ž . 2.71, r s 0.74
Effect of NNLA, MB and Õasopressin on coronary flow and autoregulation
Switching to perfusion medium containing 100 mmolrl NNLA reduced coronary flow at all perfusion pressures to Ž similar levels in control and endotoxin-treated hearts Fig.  .  1 and Fig. 2a . Parallel to the reduction in flow there was a Ž . reduction in oxygen consumption per gram wet weight to 3.1 " 0.1 mmolrmin in control hearts and 3.2 " 0.1 mmolrmin in endotoxin-treated hearts at 60 mmHg perfusion pressure, which is not significantly different between groups. With NNLA the autoregulation index was increased at all perfusion pressures in both control and Ž . endotoxin-treated hearts P -0.05 to similar levels in Ž . both groups Fig. 4c , resulting in a plateau of considerable autoregulation at perfusion pressures above 40 mmHg Inhibition of soluble guanylate-cyclase with 5 mmolrl MB reduced coronary flow at all perfusion pressures to a Ž . similar level in both groups Fig. 1 and Fig. 2b . Autoregu-Ž . lation index with MB Fig. 4d was increased at perfusion pressures from 20 to 40 mmHg and above 70 mmHg in Ž . control hearts P -0.05 and at all perfusion pressures in Ž . endotoxin-treated hearts P -0.05 to similar levels at all perfusion pressures. ArI following MB compared to before MB was not increased at 50 and 60 mmHg perfusion Ž . pressure P s NS .
Direct smooth muscle constriction with vasopressin in a concentration of 1 nmolrl that reduced flow to a similar Ž level as NNLA at 60 mmHg perfusion pressure Figs. 1 . and 2c increased ArI at 20 mmHg perfusion pressure and decreased ArI at perfusion pressures above 40 mmHg in control and endotoxin-treated hearts. Vasopressin could not eliminate differences in ArI between control and endotoxin-treated hearts in the pressure range between 30 and Ž . Ž . 70 mmHg P -0.05 of LPS versus control Fig. 4e . In all hearts coronary flow returned to the baseline value, when at the end of the series of pressure step changes, perfusion pressure was set at the initial value of 60 mmHg.
Effect of endotoxemia on reactiÕe hyperemic flow response
Endotoxemia resulted in a changed pattern of reactive Ž . hyperemia Fig. 5a . As shown in Table 1 , endotoxemia resulted in 59 " 7% increased basal flow and flow debt, 66 " 7% decreased duration of reactive hyperemia, 65 " Table 1 . Fig. 5d . Quantitative analyses of reactive hyperemic response showed no significant differences of untreated hearts with 0.1 mmolrl nitroprusside Ž . versus endotoxin-treated hearts P s NS, Table 1 .
Effect of NNLA, MB and Õasopressin on reactiÕe hyperemic response.
Perfusion of the hearts with 100 mmolrl NNLA or 5 mmolrl MB resulted in similar reactive hyperemic flow Ž . patterns of control and endotoxin-treated hearts Fig. 5b,c . In the presence of NNLA or MB reductions in basal flows, flow debt and maximum hyperemic flow were seen in Ž . control and endotoxin-treated animals P -0.05, Table 1 . NNLA reduced the duration of reactive hyperemia and flow repayment in control hearts and increased flow repay-Ž ment in control and endotoxin-treated hearts P -0.05, . Table 1 . NNLA did not change the duration of reactive Ž . hyperemia in endotoxin-treated hearts P s NS, Table 1 . MB reduced the duration of reactive hyperemia in control hearts but increased the duration of reactive hyperemia in Ž . endotoxin-treated hearts P -0.05, Table 1 . MB in-Ž creased flow repayment in endotoxin-treated hearts P -. 0.05 but did not change flow repayment in control hearts Ž . P s NS, Table 1 . Furthermore, MB resulted in increased flow repayment ratio in both control and endotoxin-treated Ž . hearts P -0.05, Table 1 .
In the presence of NNLA or MB no significant differences in basal flow, flow debt, maximal reactive flow, duration of hyperemia, flow repayment and repayment ratio were present between control and endotoxin-treated Ž . hearts P s NS, Table 1 .
In endotoxin-treated hearts, the presence of 1 nmolrl vasopressin caused a similar reduction in basal flow, flow debt and maximal reactive flow as was seen with NNLA Ž . P s NS of NNLA versus vasopressin, Table 1 and increased duration of reactive hyperemic flow, flow repay-Ž ment and repayment ratio P -0.05 of NNLA versus . vasopressin, Table 1 .
Discussion
The main finding of this study is that the excessive myocardial production of NO in isolated hearts from endotoxemic rats leads to massive coronary vasodilatation that results in dysfunction of coronary autoregulation and attenuation of myocardial reactive hyperemia. Reduction of coronary flow by inhibition of the L-argininerNOrcGMP pathway with NNLA or MB could restore this autoregulatory dysfunction, whereas direct smooth muscle constriction with vasopressin could not. These findings may bring some new insights into the pathophysiological processes leading to cardiovascular dysfunction in sepsis and septic shock.
Coronary flow autoregulation has been extensively studied both in vivo and in vitro in the isolated vessel preparaw x tion and isolated perfused heart preparation 1,3 . The present study used an isolated perfused heart preparation. In this preparation, which does no external work, oxygen demand is low so that perfusion at low pressures is tolerated without causing severe ischemia. Furthermore, oxygen consumption is kept as constant as possible minimizing variations in flow through metabolic coronary vasodilatation. Compared to the isolated vessel preparation this whole-organ preparation has the advantage that it contains all consecutive vascular segments including larger coronary arteries and small arterioles, since autoregulation of w x blood flow can be spatially organized 25,26 . However, some reservations must be made to extrapolate the findings of the present study to the in vivo situation. The isolated non-working heart preparation that was used misses the neurohumoral and metabolic input which are known to w x influence autoregulation in vivo 1 . Furthermore, changes in NO production may directly influence myocardial conw x tractility 27 , which was not measured in the preparation used. Therefore we cannot rule out that any changes in autoregulation that have been found during isolated perfusion may have been compensated for in the in vivo situation.
A hyperdynamic model of endotoxemia was used that showed increased coronary flow together with increased myocardial oxygen consumption. Although the origin of this high oxygen consumption in hearts of endotoxin-treated animals is still speculative, the increases in oxygen consumption could have directly resulted from increases in w x coronary flow, the so-called Gregg phenomenon 28,29 . This is supported by the finding that isolated hearts showed a linear increase in oxygen consumption with increases in coronary flow and increased oxygen consumption follow-Ž . ing addition of the vasodilator, nitroprusside Fig. 3 . Parallel with these observations, reduction of coronary flow by NNLA resulted in decreased oxygen consumption. w x Similar findings were made by Pohl et al. 9 in the isolated rabbit heart where NNLA reduced oxygen consumption during constant pressure perfusion but was without effect during constant flow perfusion, excluding a direct inhibitory effect of NNLA on myocardial metabolism.
Coronary autoregulation depends on the balance bew x tween competing constricting and dilating influences 1 . Autoregulatory dysfunction in endotoxin-treated hearts could therefore have resulted from defective vasoconstrictive mechanisms or an overshoot of vasodilator mechanisms. The myogenic response mediates vasoconstriction in response to increased transmural pressure and is considw x ered a major constricting force in the coronary vessels 3 . Myogenic dilation following a period of occlusion and myogenic constriction after restoration of flow is one of the mechanisms contributing to reactive hyperemia in the w x coronary vessels 24 . The mechanism responsible for the myogenic response is still incompletely understood but is ( )probably located in the vascular smooth muscle cell itself, and mediated by an increase in intracellular calcium through influx via either stretch-activated or voltage-gated w x ion channels 30,31 . Endotoxin could have induced defects in the myogenic response that may have resulted in a loss of vascular tone, autoregulatory dysfunction and altered reactive hyperemia. However, inhibition of the LargininerNOrcGMP pathway with NNLA or MB reduced basal coronary flow and prevented pressure-induced increases in coronary flow of endotoxin-treated hearts, resulting in similar levels of autoregulation to those in control hearts with NNLA or MB, whereas with vasopressin, a direct smooth muscle constrictor, differences in autoregulation between control and endotoxin-treated hearts remained. Furthermore, in endotoxin-treated hearts in the presence of NNLA or MB there was only a brief reactive hyperemic response following occlusion after which coronary flow returned to baseline levels. These results suggest that myogenic tone was well preserved following inhibition of the L-argininerNOrcGMP pathway. An overshoot in NO mediated vasodilating influences, thus counteracting myogenic vascular tone, is more likely to have caused the autoregulatory dysfunction and altered reactive hyperemic response in endotoxin-treated hearts. This view is further supported by the present finding that vasodilation with the exogenous NO donor, nitroprusside, in control hearts resulted in autoregulatory dysfunction and altered reactive hyperemic response similar to that in endotoxin-treated hearts.
Ž Earlier studies have shown that under normal i.e., . non-septic or non-endotoxemic conditions the endogenous production of NO can attenuate autoregulation by opposw x ing myogenic tone in the isolated perfused rabbit ear 32 , w x w x guinea pig heart 10 and rabbit heart 9 , and in the canine w x heart in vivo 33 . The present study is the first to show that autoregulatory dysfunction may exist in endotoxemia resulting from excessive production of NO. However, NO is not the only regulator of vascular tone. Other vasoactive factors, such as adenosine, prostaglandins, pO and pCO , 2 2 w x are known to influence vascular tone 1,34 . To what extent one or more of these metabolites may have contributed to vasodilatation and derangements in autoregulation and reactive hyperemia in the endotoxin-treated hearts is unknown.
Under physiological conditions NO plays an important w x role in myocardial reactive hyperemia 11,12 . In the present study, inhibition of the L-argininerNOrcGMP pathway in normal hearts resulted in decreased peak reactive flow, decreased duration of the hyperemic response and decreased total reactive hyperemic blood flow, which demonstrates the contribution of NO to myocardial reactive hyperemia. Although endotoxin-treated hearts showed Ž . a pattern of reactive hyperemia Fig. 5 , flow repayment was only one third of that of control hearts. Vasoconstriction through inhibition of the L-argininerNOrcGMP pathway with NNLA or MB could improve flow repayment in endotoxin-treated hearts and resulted in similar reactive hyperemic flow patterns to those in control hearts with NNLA or MB. However, also vasopressin, a direct smooth muscle vasoconstrictor, could improve flow repayment and resulted in a 'normal' reactive hyperemia pattern. These results suggest that an excessive coronary flow secondary to endogenous NO production minimized flow reserve and blunted the reactive hyperemic response in endotoxintreated hearts.
In conclusion, the massive coronary vasodilatation due to increased myocardial production of NO during sepsis and endotoxemia may result in dysfunction of coronary autoregulation. Increasing vascular tone by inhibition of the L-argininerNOrcGMP pathway with NNLA or MB can restore these changes, unlike direct smooth muscle constriction with vasopressin. These findings may help us understand some of the pathophysiological processes that lead to cardiovascular dysfunction during sepsis and endotoxemia. Improvement of vascular autoregulation may be one of the mechanisms by which inhibitors of the LargininerNOrcGMP pathway contribute to correction of the cardiovascular derangements during human septic shock w x 35 .
